Financial constraint is a major difficulty for organ donors and it is crucial to take the burden off their shoulders and their families. Experts urge Americans to find ethical ways to get rid of financial hindrance to organ donation.
In addition to removal of financial barriers, they would also like to see careful consideration and testing of potential financial incentives for organ donation. "Every person in the chain of an organ donation, except one, profits," said Daniel Salomon, Medical Director of the kidney and pancreas transplant program at Scripps Health, San Diego.
Kidney Transplantation
Since the early times, the novel idea of transplanting tissues and other body parts from one organism to the other has captured the imagination of successive generations.
Advertisement
Living donors incur out-of-pocket expenses averaging $5,000. The insurance of recipient covers the donor's medical expenses, but it won't cover transportation, lodging, childcare and lost wages. Families of deceased donors may face higher hospital and funeral costs resulting from donation.
"Donor costs should be incorporated into the cost of the transplant. The donor should bear no economic detriment," said Tom Mone, CEO of OneLegacy.
![Transplantation]( "Transplantation")
Organ and tissue transplantation can give a second chance at life to thousands of people. Learn more about this interesting procedure.
While there's agreement that financial barriers prevent too many potential donors from proceeding with the surgery, incentives are a murky territory. Offering incentives to living donors, however, is so ethically charged. We don't know if that would result in exploitation or undue inducement, said Elisa Gordon, Medical anthropologist, Northwestern University.
"We have a responsibility to living donors. But, we basically take their kidney and say goodbye," said Salmon. He maintains that donors should receive lifetime health coverage, while other working group members have suggested coverage for a certain time.
Working group members say a balance should be struck between burdensome donation costs and compensation, and this balance can be identified in careful consideration of other incentives- but not cash. "We need to initiate discussions with a broad group of stakeholders in this country, starting with the patients, families and payers," said Salomon.
Source: Medindia
Transplantation
Organ and tissue transplantation can give a second chance at life to thousands of people. Learn more about this interesting procedure.
Advertisement
While there's agreement that financial barriers prevent too many potential donors from proceeding with the surgery, incentives are a murky territory. Offering incentives to living donors, however, is so ethically charged. We don't know if that would result in exploitation or undue inducement, said Elisa Gordon, Medical anthropologist, Northwestern University.
"We have a responsibility to living donors. But, we basically take their kidney and say goodbye," said Salmon. He maintains that donors should receive lifetime health coverage, while other working group members have suggested coverage for a certain time.
Working group members say a balance should be struck between burdensome donation costs and compensation, and this balance can be identified in careful consideration of other incentives- but not cash. "We need to initiate discussions with a broad group of stakeholders in this country, starting with the patients, families and payers," said Salomon.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Organ Donation News
An analysis of data from donors suggests donor hearts from patients who were COVID-19 positive could place transplant patients at increased risk of mortality.
Patients subjected to delayed transplantation using 10°C static lung preservation had a better outcome compared to patients transplanted performed using standard methods.
Researchers are hoping to test the antibody IL-15 in organ transplant patients to reduce chronic organ rejection.
Research may speed the identification of patients who need liver transplants by analyzing blood samples to look for biomarkers associated with liver failure.
The discovery of T cells involvement in graft-versus-host disease is a vital step in finding more effective life-saving treatments for bone marrow transplant.